TY - JOUR
AB - Cardiac fibrosis independently predicts adverse outcomes in heart failure (HF), yet no Food and Drug Administration–approved therapy directly targets fibrotic remodeling in the heart. To address this unmet clinical need, we used a multidimensional drug ...
BT - Science
LA - en
N2 - Cardiac fibrosis independently predicts adverse outcomes in heart failure (HF), yet no Food and Drug Administration–approved therapy directly targets fibrotic remodeling in the heart. To address this unmet clinical need, we used a multidimensional drug ...
T2 - Science
TI - Targeting an atypical G protein–coupled receptor signaling pathway for cardiac fibrosis therapy
UR - https://www.science.org/doi/10.1126/science.aej5896
Y2 - 2026-09-25
ER -